ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · IEX Real-Time Price · USD
0.826
-0.054 (-6.19%)
At close: Jul 19, 2024, 4:00 PM
0.910
+0.084 (10.17%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $9.95 million as of July 22, 2024. Its market cap has decreased by -34.94% in one year.
Market Cap
9.95M
Enterprise Value
11.63M
1-Year Change
-34.94%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $9.95M, a decrease of -87.48%. That is a compound annual growth rate of -50.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 9.00M | 7.14% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 10.92M |
| Inhibikase Therapeutics | 10.82M |
| Coeptis Therapeutics | 10.62M |
| MIRA Pharmaceuticals | 10.18M |
| Moleculin Biotech | 9.97M |
| Plus Therapeutics | 9.93M |
| Tonix Pharmaceuticals Holding | 9.78M |
| Pieris Pharmaceuticals | 9.57M |